Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells
2004 · BMC Pharmacology · 19 citations
https://doi.org/10.1186/1471-2210-4-31